A Study in Participants With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is:
- To compare blood glucose (blood sugar) control on LY2605541 with insulin glargine after
26 weeks of treatment.
- To compare the rate of night time hypoglycemia (low blood glucose) on LY2605541 with
insulin glargine during 26 weeks of treatment.
- To compare the number of participants on LY2605541 reaching blood glucose targets
without hypoglycemia episodes at night to those taking insulin glargine after 26 weeks
of treatment.
- To compare the rate of hypoglycemia over a 24-hour period on LY2605541 with insulin
glargine during 26 weeks of treatment.